Conference abstract · 11 Aug 2015
Conference abstractPublished 22 Nov 2013
Clerodendrum capitatum in treating brain disorder
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Clerodendrum capitatum is used in traditional medicine in Cameroon to treat brain diseases like headaches, epilepsy and memory disorders. The pharmacological properties of this pant were studies in animal memory models (the open field test, the novel object recognition test and the T maze test). The phytochemical characterization showed that the decoction of Clerodendrum capitatum contains alkaloid, tannins, saponins, triterpenes, and anthraquinon. In open field test, Clerodendrum capitatum increased crossing and center time even in mice treated with scopolamine. In the presence of Clerodendrum capitatum, the latency time for the novel object was decreased by 33.3% while the one of the familiar object was increased. Controversially, the exploratory time for the novel object was more increased when compare to the familiar object (315.9% and 28.6% respectively), and the recognition increased from 47.3% in the control group to 76.9% in mice treated with the decoction at the dose of 139.1 mg/kg. In retention phase in T maze, the increase of the number of entries and the time spend in arms induced by the Clerodendrum capitatum was greater in the preferred arm than in the other arm even in the presence of scopolamine. The plant also decreased latency time of choosing an arm in retention. The results were compared to piracetam. In addition, Clerodendrum capitatum decreased the acethyl cholinesterase activity even in mice treated with scopolamine. Clerodendrum capitatum could be very helpful in traditional medicine to enhance memory, and may contain potential compounds efficient in the treatment of memory lost.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 18 Nov 2014
Intranasal insulin, deferoxamine and therapeutic cells bypass the blood-brain barrier to treat Alzheimer�s and other brain disorders
Research article · 7 Aug 2017
Efficacy of Virus Inhibitory Agent (VIA), Isolated from Host Plants Treated with Purified Clerodendrum aculeatum Phytoprotein Alone and in Combination with Bioenhancers
Opinion · 14 Oct 2025
Brain connectivity: Understanding and treating condition
Article · 18 Apr 2024
Developing a Neurovascular Embolization Coil with Delivery System to Treat Brain Aneurysms
More from this journal
The newest in Journal of Alzheimers Disease & Parkinsonism.
Commentary · 8 Jun 2026
Cognitive Concerns: The Side Effects of Surgery in Alzheimer's Patients
Perspective · 8 Jun 2026
Oxidative Stress and Its Role in Neuronal Degeneration: Mechanisms and Implications
Commentary · 8 Jun 2026
Understanding the Pathophysiology of Prion-Induced Dementia
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Alzheimers Disease & Parkinsonism
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Ngo Bum Elisabeth”
